WHO ICTRP trial
Imaging of Prostate Cancer Tumours Using 177Lu-NTA-476
ACTRN12625001028493 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12625001028493 |
|---|---|
| Public title | Imaging of Prostate Cancer Tumours Using 177Lu-NTA-476 |
| Scientific title | A Phase 0, Single-centre, Open-label, Non-randomized Imaging Study to Investigate the Safety and Dosimetry of 177Lu-NTA-476 in Prostate Cancer Patients |
| Primary sponsor | GenesisCare |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 0 |
| Countries | Australia |
| Conditions | Prostate Cancer; Prostate Cancer;Cancer - Prostate |
| Interventions | This is a single-arm, single-centre, open-label, non-randomized imaging trial in men with prostate cancer. Participants will undergo prostate specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) imaging… |
| Registration date | Sep 17, 2025 |
| Target size | 10 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: